Landscape Capital Management, L.L.C. Biomarin Pharmaceutical Inc Transaction History

Landscape Capital Management, L.L.C.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$80.14 - $106.07 $166,530 - $220,413	-2,078 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$93.92 - $105.72 $195,165 - $219,686	2,078 New	2,078 $202,000
Q1 2018 May 11, 2018	SELL	$77.67 - $92.63 $924,350 - $1.1 Million	-11,901 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$80.76 - $95.13 $961,124 - $1.13 Million	11,901	11,901 $1.06 Million

635

178M

2.01M

1.28M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $11.8B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Landscape Capital Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Landscape Capital Management, L.L.C. with notifications on news.